Petmed Express Stock Performance
| PETS Stock | USD 4.11 0.05 1.20% |
The company holds a Beta of 0.94, which implies possible diversification benefits within a given portfolio. PetMed Express returns are very sensitive to returns on the market. As the market goes up or down, PetMed Express is expected to follow. PetMed Express has an expected return of -0.8%. Please make sure to check PetMed Express value at risk and rate of daily change , to decide if PetMed Express performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days PetMed Express has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in May 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return (1.20) | Five Day Return (3.97) | Year To Date Return (45.78) | Ten Year Return (68.26) | All Time Return (50.93) |
Forward Dividend Yield 0.1307 | Last Split Factor 3:1 | Forward Dividend Rate 1.2 | Dividend Date 2023-08-18 | Ex Dividend Date 2023-08-11 |
1 | PetMed Express Set to Announce Earnings on Thursday - MarketBeat | 01/31/2024 |
2 | PetMeds Announces Selected Preliminary Third Quarter Financial Results | 02/08/2024 |
3 | PetMed Express, Inc. Q3 2024 Earnings Call Transcript | 02/09/2024 |
4 | PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q | 02/15/2024 |
5 | PetMeds to Give Away Free Pet Food for a Year to Three Lucky Pet Owners and 1,000 in PetMeds Credits to Three Local Animal Shelters | 02/16/2024 |
6 | Numerai GP LLC Buys Shares of 21,033 PetMed Express, Inc. | 02/27/2024 |
7 | Q3 2023 Petmed Express Inc Earnings Call Transcript | 03/06/2024 |
8 | 7 Penny Stocks to Sell in March Before They Crash Burn | 03/18/2024 |
9 | Acquisition by Purcel Diana G of 7500 shares of PetMed Express subject to Rule 16b-3 | 03/25/2024 |
10 | PETS Stock Earnings PetMed Express Misses EPS, Beats Revenue for Q3 2024 | 04/15/2024 |
| Begin Period Cash Flow | 111.1 M | |
| Total Cashflows From Investing Activities | -10.3 M |
PetMed |
PetMed Express Relative Risk vs. Return Landscape
If you would invest 693.00 in PetMed Express on January 17, 2024 and sell it today you would lose (282.00) from holding PetMed Express or give up 40.69% of portfolio value over 90 days. PetMed Express is currently does not generate positive expected returns and assumes 2.239% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than PetMed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PetMed Express Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PetMed Express' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PetMed Express, and traders can use it to determine the average amount a PetMed Express' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.3576
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PETS |
Estimated Market Risk
| 2.24 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.8 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.36 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PetMed Express is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PetMed Express by adding PetMed Express to a well-diversified portfolio.
PetMed Express Fundamentals Growth
PetMed Stock prices reflect investors' perceptions of the future prospects and financial health of PetMed Express, and PetMed Express fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PetMed Stock performance.
| Return On Equity | -0.0483 | ||||
| Return On Asset | -0.0264 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 33.33 M | ||||
| Shares Outstanding | 21.15 M | ||||
| Price To Earning | 12.75 X | ||||
| Price To Book | 0.78 X | ||||
| Price To Sales | 0.33 X | ||||
| Revenue | 256.86 M | ||||
| Gross Profit | 78.08 M | ||||
| EBITDA | 2.12 M | ||||
| Net Income | 233 K | ||||
| Cash And Equivalents | 105.41 M | ||||
| Cash Per Share | 5.21 X | ||||
| Current Ratio | 5.61 X | ||||
| Book Value Per Share | 5.57 X | ||||
| Cash Flow From Operations | 27.8 M | ||||
| Earnings Per Share | (0.30) X | ||||
| Market Capitalization | 88.18 M | ||||
| Total Asset | 164.12 M | ||||
| Retained Earnings | 105.49 M | ||||
| Working Capital | 94.95 M | ||||
| Current Asset | 67.63 M | ||||
| Current Liabilities | 7.08 M | ||||
About PetMed Express Performance
To evaluate PetMed Express Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when PetMed Express generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare PetMed Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand PetMed Express market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents PetMed's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 42.97 | 63.61 | |
| Return On Tangible Assets | 0 | 0 | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | 0 | 0 | |
| Return On Equity | 0 | 0 |
Things to note about PetMed Express performance evaluation
Checking the ongoing alerts about PetMed Express for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PetMed Express help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PetMed Express generated a negative expected return over the last 90 days | |
| PetMed Express has a strong financial position based on the latest SEC filings | |
| About 75.0% of the company shares are owned by institutional investors | |
| Latest headline from investorplace.com: PETS Stock Earnings PetMed Express Misses EPS, Beats Revenue for Q3 2024 |
- Analyzing PetMed Express' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PetMed Express' stock is overvalued or undervalued compared to its peers.
- Examining PetMed Express' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PetMed Express' management team can have a significant impact on its success or failure. Reviewing the track record and experience of PetMed Express' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PetMed Express' stock. These opinions can provide insight into PetMed Express' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for PetMed Stock analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is PetMed Express' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PetMed Express. If investors know PetMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PetMed Express listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.59) | Dividend Share 1.2 | Earnings Share (0.30) | Revenue Per Share 13.302 | Quarterly Revenue Growth 0.086 |
The market value of PetMed Express is measured differently than its book value, which is the value of PetMed that is recorded on the company's balance sheet. Investors also form their own opinion of PetMed Express' value that differs from its market value or its book value, called intrinsic value, which is PetMed Express' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PetMed Express' market value can be influenced by many factors that don't directly affect PetMed Express' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PetMed Express' value and its price as these two are different measures arrived at by different means. Investors typically determine if PetMed Express is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PetMed Express' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.